Clinical Trial Update: Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy [Phase 3]

View source ↗

Summary

Phase 3 trial update for NPO-11 in patients undergoing gastrointestinal endoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Endoscopy Procedures-related Indications

Drugs mentioned

• NPO-11 (NPO-11)

Snippet

Sponsor: Nihon Pharmaceutical Co., Ltd | Conditions: Patients Undergoing Gastrointestinal Endoscopy | Phase 3 | Status: COMPLETED